Results 101 to 110 of about 28,236 (118)

Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis

Clinical Therapeutics, 2017
Linong Ji, Yang Xu, Siyan Zhan
exaly  

Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors

Bioorganic and Medicinal Chemistry Letters, 2006
Carl Crysler
exaly  

The Unique Properties of Dipeptidyl-peptidase IV (DPP IV I CD26) and the Therapeutic Potential of DPP IV Inhibitors

Current Medicinal Chemistry, 1999
Koen Augustyns, F Goossens, C Durinx
exaly  

Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus

Circulation: Heart Failure, 2017
Kwan-Woo Lee, Hae Jin Kim, Young-Gun Kim   +2 more
exaly  

Safety of dipeptidyl peptidase 4 inhibitors: a perspective review

Therapeutic Advances in Drug Safety, 2014
Thomas Karagiannis, Apostolos Tsapas
exaly  

Effect of Dipeptidyl-Peptidase 4 Inhibitors on Circulating Oxidative Stress Biomarkers in Patients with Type 2 Diabetes Mellitus

Antioxidants, 2020
Maura Lodovici, Edoardo Mannucci, Lisa Giovannelli   +2 more
exaly  

Dipeptidyl peptidase-4 inhibitors: Anti-diabetic drugs with potential effects on cancer

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2019
Ahmed M Kabel
exaly  

Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes

Expert Opinion on Investigational Drugs, 2008
Nasser Mikhail
exaly  

Plant Dipeptidyl Peptidase-IV Inhibitors as Antidiabetic Agents: A Brief Review

Future Medicinal Chemistry, 2018
Yingying Jiang, Hongwei Gao
exaly  

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-Analysis

Annals of Pharmacotherapy, 2012
Karen Rascati, Chanhyun Park, Haesuk Park   +2 more
exaly